4.40 USD
▼-1.15-20.72%
盘后 5.82 0.00%
2026-09-15
市值
$151.33M
市盈率
—
EPS
-5.27
股息率
—
52 周区间
2.86 – 16.34
成交量
650.23K
Beta
1.35
目标价
17.50
52W 低 2.8652W 高 16.34
价格走势
公司简介
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.